Hong Kong Drugmaker Warned for Quality Control, Procedural Shortcomings

Drug Industry Daily
A A
Wong Lap Kwong Medicine Company drew a warning from the FDA for failing to identify active pharmaceutical ingredients and to establish procedures for numerous basic functions in its Hong Kong facility.

To View This Article:

Login

Subscribe To Drug Industry Daily